Discovery of a highly potent and selective Bruton’s tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma

Lignende værker

• Richter Transformation to Hodgkin Lymphoma on Bruton Tyrosine Kinase Inhibitor Therapy
  af: Taneja, Alankrita, et al.
  Udgivet: (2018)
• Discovery of Potent and Selective Tricyclic Inhibitors of Bruton’s Tyrosine Kinase with Improved Druglike Properties
  af: Wang, Xiaojing, et al.
  Udgivet: (2017)
• Molecular Drug Discovery of Single Ginsenoside Compounds as a Potent Bruton’s Tyrosine Kinase Inhibitor
  af: Keun Woo Lee, et al.
  Udgivet: (2020-04-01)
• Molecular Drug Discovery of Single Ginsenoside Compounds as a Potent Bruton’s Tyrosine Kinase Inhibitor
  af: Lee, Keun Woo, et al.
  Udgivet: (2020)
• Discovery of 5-Phenoxy-2-aminopyridine Derivatives as Potent and Selective Irreversible Inhibitors of Bruton’s Tyrosine Kinase
  af: Lee, Eun, et al.
  Udgivet: (2020)